HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
BIOBOARD - EUROPE
Gecko Biomedical's co-founders demonstrate a 'bio-inspired' tissue adhesive that shows promise for minimally invasive heart surgery and vessel repair
Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, have published data demonstrating the potential of its paradigm-shifting technologies for minimally invasive reconstructive heart surgery.

'Bio-inspired' biodegradable surgical glue repairs defects of the heart and blood vessels

The data describe a revolutionary biodegradable and biocompatible surgical glue that was inspired by adhesive mechanisms observed in nature that function in challenging yet comparable (wet and dynamic) environments to those found in the body.

The 'bio-inspired' glue described is non-toxic, binds strongly to tissues offering a leak-proof seal on demand, and works well in the presence of actively contracting tissues and blood flow. The authors demonstrate how the adhesive, alone or in conjunction with a biodegradable patch, can effectively be used to repair defects (ruptures) of the heart and blood vessels during minimally invasive procedures.

Precise control of the wound closure process could shift the surgical paradigm

The glue is based on the combination of safe, naturally occurring compounds to form a biocompatible pre-polymer with tunable adhesive and mechanical properties. The glue is soft and elastic when applied to the wet surfaces of the wounds where it adheres gently to the tissues, permitting fine adjustments or repositioning when used with the patch. The glue is activated (polymerized) upon exposure to ultraviolet (UV) light to form a strong, leak-proof but flexible seal, giving the surgeon full control of the process. The adhesive can be engineered with mechanical characteristics similar to arteries and the digestive system, where initial applications are targeted. The authors also describe how the composition of the pre-polymer can be adjusted for strength or rate of biodegradation to suit the wound being repaired.

Jeffrey Karp, from the Department of Medicine at the Brigham and Women's Hospital, a co-founder of Gecko Biomedical and co-senior author of the study, said: "The tissue adhesive that we developed satisfies a long list of design criteria including biodegradation, biocompatibility, ability to strongly adhere on-demand to tissue with a water-tight seal in the presence of flowing blood, and elastic properties to accommodate cyclical forces such as those exerted by a beating heart or blood vessel. It offers the potential to reduce the invasiveness of surgical procedures, reduce operative times, and improve outcomes for patients. "

"This platform of adhesive elastomers is truly versatile to address multiple meaningful applications in the clinic, " said Maria N. Pereira, Ph.D., co-first author of the study who was previously in the Department of Medicine at the Brigham and Women's Hospital and is now Head of Adhesive Technologies at Gecko Biomedical.

Christophe Bancel, Chief Executive Officer of Gecko Biomedical, added: "The science and research supporting the development of Gecko's liquid film adhesive and patch technologies is of the highest quality. What has been achieved so far is very exciting and we are focused on undertaking the further necessary steps to get these innovative products into the hands of surgeons within the next few years, for the benefit of patients. "

Source: PR Newswire

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017: Industry players optimistic of future
news Nestlé Introduces their Singapore R&D Centre
news Vitafoods Asia Elevates 2017 Learning Programme
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy